KRIBB11
- CAS NO.:342639-96-7
- Empirical Formula: C13H12N6O2
- Molecular Weight: 284.27
- MDL number: MFCD30182306
- Update Date: 2026-04-21 10:31:43
What is KRIBB11?
The Uses of KRIBB11
KRIBB 11 is a heat shock factor (HSF) inhibitor that induces apoptosis in cancer cells. KRIBB 11 exhibits anticancer properties.
Storage
Store at -20°C
Properties of KRIBB11
| Boiling point: | 534.9±50.0 °C(Predicted) |
| Density | 1.531±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO:27.0(Max Conc. mg/mL);94.98(Max Conc. mM) |
| form | powder |
| pka | 13.59±0.40(Predicted) |
| color | yellow to orange |
Safety information for KRIBB11
Computed Descriptors for KRIBB11
New Products
Dexamethasone Sodium Phosphate p-Anisaldehyde m-Tolualdehyde 2-Bromobenzaldehyde 4-Fluorobenzaldehyde 1-Propyl-4-piperidone 3-Amino-3-(3-fluorophenyl)propanoic acid Raloxifene EP Impurity D N-Nitroso Nortriptyline Nitroso Irbesartan 2-(p-Tolyl)acetaldehyde Sulfonic acid Impurity 2,2-dibromo-1-cyclopropyl-2-(2-fluorophenyl)ethan-1-one 5-Chloro-2-Methoxy-4-Picoline 2-Amino-6-nitrobenzoic Acid (6-Nitroanthranilic acid) Cis-3,5 Diacetoxy-1-cyclopentene 3-Bromo-2-Methoxy-4-Methylpyridine 2-Amino-5-Chloro-3-Nitro-6-picoline 3-Methoxy-5-methylpyrazin-2-amine Pentachlorobenzonitrile Budesonide Nicotinic acid RAPAMYCIN Alpha CyclodextrinYou may like
-
Kribb11 95% CAS 342639-96-7View Details
342639-96-7 -
Heat Shock Factor 1 Inhibitor, KRIBB11 CAS 342639-96-7View Details
342639-96-7 -
12029-98-0 >98%View Details
12029-98-0 -
Hydrocortisone 50-23-7 >98%View Details
50-23-7 -
106-43-4 Parachlorotoluene >99%View Details
106-43-4 -
Pyrrolidin >98%View Details
123-75-1 -
cis-p-Menth-2,8-diene-1-ol 7212-40-0 >98%View Details
7212-40-0 -
Para Chloro toluene (PCT) 106-43-4 >99%View Details
106-43-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
